7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Protein expression of major hepatic uptake and efflux drug transporters in human pediatric (n=69) and adult (n=41) livers was quantified by LC-MS/MS. Transporter protein expression of OCT1, OATP1B3, P-gp and MRP3 was age-dependent. Particularly, significant differences were observed in transporter expression (p <0.05) between the following age-groups: neonates vs. adults (OCT1, OATP1B3, P-gp), neonates or infants vs. adolescents and/or adults (OCT1, OATP1B3 and P-gp), infants vs. children (OATP1B3 and P-gp) and adolescents vs. adults (MRP3). OCT1 showed the largest increase, of almost 5-fold, in protein expression with age. Ontogenic expression of OATP1B1 was confounded by genotype and was revealed only in livers harboring SLCO1B1*1A/*1A. In livers > 1 year, tissues harboring SLCO1B1*14/*1A showed 2.5-fold higher (P<0.05) protein expression than SLCO1B1*15/*1A. Integration of these ontogeny data in physiologically based pharmacokinetic (PBPK) models will be a crucial step in predicting hepatic drug disposition in children.

          Related collections

          Author and article information

          Journal
          0372741
          3058
          Clin Pharmacol Ther
          Clin. Pharmacol. Ther.
          Clinical pharmacology and therapeutics
          0009-9236
          1532-6535
          15 June 2016
          13 August 2016
          October 2016
          01 October 2017
          : 100
          : 4
          : 362-370
          Affiliations
          [1 ]Department of Pharmaceutics, University of Washington, Seattle, P.O. Box 357610, WA 98195, USA
          [2 ]Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Children's Mercy, University of Missouri-Kansas City, Kansas City, MO, 64108
          [3 ]School of Medicine, University of Missouri-Kansas City, Kansas City, MO, 64108
          [4 ]Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck Sharp & Dohme Corporation, Kenilworth, NJ, 07033, USA
          [5 ]Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co., Rahway, NJ 07065, USA
          [6 ]Biogen, 14 Cambridge Center, Cambridge, MA, 02142
          Author notes
          [1 ] Corresponding authors: Jashvant D. Unadkat, Department of Pharmaceutics, University of Washington, Seattle, P.O. Box 357610, WA 98195, USA. Phone: +1-206-685-2869. Fax: +1-206-543-3204. jash@ 123456u.washington.edu
          [2 ]Bhagwat Prasad, Department of Pharmaceutics, University of Washington, Seattle, P.O. Box 357610, WA 98195, USA. Phone: +1-206-616-8666. Fax: +1-206-543-3204. bhagwat@ 123456u.washington.edu
          Article
          PMC5017908 PMC5017908 5017908 nihpa795000
          10.1002/cpt.409
          5017908
          27301780
          71b3b554-54a9-4124-ac78-6103d3741cba
          History
          Categories
          Article

          Transporter ontogeny,developmental expression of transporters,transporter protein quantification,hepatic transporters,pharmacogenetics,transporter proteomics

          Comments

          Comment on this article